by The m-RNA synthesis service market involves the manufacturing and selling of synthetic messenger RNA (mRNA) by multiple contract development and manufacturing organizations (CDMOs) on a commercial and research scale. Messenger RNA (mRNA) is a single-stranded RNA molecule that carries codes from DNA in the cell’s nucleus to the cytoplasm, where it translates the genetic information to make the proteins needed for the cell’s activities. Currently, mRNA is being used in various therapeutic areas like oncology, vaccines, regenerative medicine and protein replacement therapies. Advances in nanoparticle-based drug delivery and gene editing have expanded mRNA applications in biomedical research, biomanufacturing and clinical studies. Promising clinical trials in cancer immunotherapy and COVID-19 vaccines have fueled interest in mRNA therapeutics.
The global m-RNA Synthesis Service Market is estimated to be valued at US$ 6438.6 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The m-RNA Synthesis Service Market is expected to be flourished by growing demand for m-RNA therapeutics. mRNA therapeutics provides several advantages over conventional drugs like ability to develop vaccines and proteins rapidly, enabling quick responses to disease outbreaks like COVID-19 pandemic. The success of mRNA COVID-19 vaccines has boosted research on mRNA therapeutics for conditions like cancer, rare diseases, and cystic fibrosis. Further, rising geriatric population vulnerable to chronic diseases and evolving nanotechnology for efficient mRNA delivery systems will continue to drive mRNA therapeutics development.
The global market is primarily driven by the growing usage of mRNA therapeutics due its advantages over conventional drug therapies. The extraordinary capability of mRNA therapeutics to produce effective vaccines rapidly against new and mutating viruses has propelled its demand. Moreover, mRNA therapeutics provide flexible solutions to target proteins intracellularly without risk of integration into the host genome. This reduced toxicity and enhanced efficiency of mRNA has expanded its application in oncology, metabolic disorders and cardiovascular therapies.
Segment Analysis
The m-RNA synthesis service market can be segmented into m-RNA design services, m-RNA synthesis services and others. Among these, the m-RNA synthesis services segment dominates the market and accounts for over 45% share owing to high demand for custom made m-RNA. The segment is further dominated by non-coding m-RNA synthesis which is majorly used in therapeutics development and cell engineering research.
PEST Analysis
Political: The m-RNA synthesis market is positively impacted by supportive regulations and government funding for R&D activities in gene therapies and vaccines.
Economic: The strong economic growth globally has increased healthcare spending which drives the market. The market is expected to grow rapidly with ongoing clinical trials and new product launches.
Social: Increasing awareness about personalized medicine and gene therapies has boosted research activities fuelling demand.
Technological: Advancements in gene editing and custom m-RNA synthesis techniques have augmented applications in therapeutic development and bioproduction.
Key Takeaways
The Global M-RNA Synthesis Service Market Demand is expected to witness high growth over the forecast period. The global m-RNA Synthesis Service Market is estimated to be valued at US$ 6438.6 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030.
North America currently dominates the market and is expected to maintain its leading position owing to presence of major players and research organizations in the US. The European region is also expected to grow significantly during the forecast period led by investments in R&D by pharmaceutical companies in the UK and Germany.
Key players operating in the m-RNA synthesis market are Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei. Huzhou City Linghu Xinwang Chemical Co., Ltd and DFE Pharma are the major players catering to custom synthesis services. Rayonier Advanced Materials and Mingtai Chemical Co., Ltd also offer platform technologies for large scale m-RNA production.
Note:
Source: Coherent Market Insights, Public sources, Desk research
We have leveraged AI tools to mine information and compile it
